We are a clinical-stage therapeutics innovator transforming how brain diseases are treated. Through a precision, technology-driven focused ultrasound platform, we deliver highly personalized therapies designed around each patient's unique biology, anatomy, and clinical needs pushing the boundaries of what's possible in neuroscience.
Promising science is too often limited not by the therapy itself, but by delivery.
Our platform redefines how therapies reach the brain, combining precision delivery with broad therapeutic compatibility and real-world scalability. By enabling non-invasive, targeted access across the blood-brain barrier, Lotus Neuro transforms existing and emerging treatments into more effective CNS therapies, bridging the gap between innovation and patient impact.
Non-invasive, targeted focused ultrasound enables real-time, repeatable delivery across the blood-brain barrier, anywhere in the brain.
Modality-agnostic platform compatible with small molecules, biologics, oligos, gene, and cell therapies, without requiring drug redesign.
A turnkey clinical and commercial infrastructure with established workflows, global networks, reimbursement pathways, and durable IP.
Breakthroughs in CNS therapy will come from combining the best of drug innovation with precision delivery. Lotus Neuro pairs focused ultrasound with existing and emerging therapeutics to achieve targeted, non-invasive delivery across the blood-brain barrier without altering the drug itself. With a turnkey, clinic-ready platform, we help partners accelerate development, enhance efficacy, and unlock the full potential of their pipelines.
Get in touchWhether you're a therapeutics partner, a clinical site, or exploring a role with us, we'd love to hear from you.
Your message is on its way to the Lotus Neuro team.
